Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.

Researchers reevaluated the use of opioid prescriptions in an acute palliative care unit among patients with advanced cancer.

Higher education linked to higher AI acceptance; concern for bias greater in Hispanic, non-Hispanic Black versus White participants.

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.